ACTIVE

hemalex.bio

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

71,4 k €

+1605.2% YoY

Gross margin

135,8 k €

+272.4% YoY

Equity

415,9 k €

-9.5% YoY

What does hemalex.bio do?

hemalex.bio is a Private limited company incorporated in 2011. Its registered office is in Brasschaat.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0835.954.116

Incorporation

28/04/2011

Legal form

Private limited company

Registered office

Door Verstraetelei 28
2930 Brasschaat · FlandreSee on map

Contributed capital

12 400,00 €

Latest accounts

31/12/2025

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 13 financial years

	2025		2024		2023		2022		2021		2019		2018		2017		2016		2015		2014		2013		2012
Income statement
Gross margin	135,8 k €	+272%	36,5 k €	-31.4%	53,1 k €	-71.9%	188,9 k €	-13.7%	219 k €	+80.3%	121,4 k €	-3.1%	125,3 k €	-39.1%	205,9 k €	+16.3%	177 k €	+52.0%	116,5 k €	+338%	26,6 k €	-69.9%	88,5 k €	-55.4%	198,5 k €
EBITDA	131,2 k €	+309%	32,1 k €	-33.1%	48 k €	-74.5%	188,5 k €	-13.4%	217,5 k €	+81.0%	120,2 k €	-3.2%	124,2 k €	-37.3%	198 k €	+12.9%	175,3 k €	+137%	73,8 k €	+183%	26,1 k €	-70.3%	88 k €	-55.5%	197,8 k €
Operating result	105,4 k €	+2653%	3,8 k €	-80.5%	19,6 k €	-87.7%	159,2 k €	-16.1%	189,8 k €	+85.1%	102,5 k €	-3.2%	105,9 k €	-41.6%	181,5 k €	+16.4%	155,9 k €	+188%	54,1 k €	+195%	18,3 k €	-77.7%	82,2 k €	-57.1%	191,9 k €
Net result	71,4 k €	+1605%	-4,7 k €	-141%	11,4 k €	-89.7%	110,8 k €	-16.2%	132,2 k €	+95.1%	67,7 k €	+11.5%	60,8 k €	-42.4%	105,6 k €	+9.8%	96,1 k €	+1538%	5,9 k €	-43.7%	10,4 k €	-85.5%	72 k €	-40.8%	121,5 k €
Balance sheet
Equity	415,9 k €	-9.5%	459,7 k €	-13.6%	532,2 k €	-8.5%	581,5 k €	+0.9%	576,3 k €	+14.9%	501,7 k €	+15.6%	434 k €	+16.3%	373,2 k €	+39.5%	267,6 k €	+56.1%	171,5 k €	+3.5%	165,6 k €	-5.9%	175,9 k €	+69.3%	103,9 k €
Total assets	609,6 k €	+6.6%	571,7 k €	-10.1%	635,9 k €	+5.5%	602,4 k €	-16.4%	720,6 k €	+6.8%	674,8 k €	+14.6%	588,8 k €	-2.8%	606 k €	+7.0%	566,3 k €	+12.8%	502,2 k €	+139%	210,4 k €	-9.3%	232 k €	+19.7%	193,8 k €
Cash	180,6 k €	+61.8%	111,6 k €	-19.3%	138,3 k €	+10.7%	124,9 k €	-55.0%	277,4 k €	+3.9%	267,1 k €	+77.6%	150,3 k €	+2.7%	146,4 k €	+38.6%	105,6 k €	+242%	30,9 k €	-76.8%	132,9 k €	-6.9%	142,7 k €	+7.1%	133,3 k €
Debts	193,7 k €	+72.9%	112,1 k €	+8.1%	103,7 k €	+396%	20,9 k €	-85.5%	144 k €	-16.8%	173,1 k €	+11.8%	154,8 k €	-33.5%	232,8 k €	-22.1%	298,7 k €	-8.6%	326,9 k €	+667%	42,6 k €	+169%	15,9 k €	-81.5%	85,6 k €

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 2 ended

Active mandates

KOEN HUYGENS

Director

Active

Ended mandates

Koen Huygens

Manager · since 28 avril 2011

Ended

Koen Huygens

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
Andara Therapeutics● Active	1029.957.579
LFSCNC● Active	0646.819.259

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	11/08/2026	10/07/2025	10/10/2024	22/11/2023	11/07/2022	28/09/2021
General meeting	29/07/2026	30/06/2025	04/10/2024	27/10/2023	30/06/2022	27/09/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

14 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	29/07/2026	11/08/2026	Dutch	PDF
Micro model	31/12/2024	30/06/2025	10/07/2025	Dutch	PDF
Micro model	31/12/2023	04/10/2024	10/10/2024	Dutch	PDF
Micro model	31/12/2022	27/10/2023	22/11/2023	Dutch	PDF
Micro model	31/12/2021	30/06/2022	11/07/2022	Dutch	PDF
Micro model	31/12/2020	27/09/2021	28/09/2021	Dutch	PDF
Micro model	31/12/2019	06/04/2020	31/08/2020	Dutch	PDF
Micro model	31/12/2018	01/04/2019	29/08/2019	Dutch	PDF
Micro model	31/12/2017	02/04/2018	16/07/2018	Dutch	PDF
Micro model	31/12/2016	03/04/2017	29/08/2017	Dutch	PDF
Abridged model	31/12/2015	05/04/2016	31/08/2016	Dutch	PDF
Abridged model	31/12/2014	07/04/2015	22/04/2015	Dutch	PDF
Abridged model	31/12/2013	22/04/2014	19/05/2014	Dutch	PDF
Abridged model	31/12/2012	08/04/2013	06/05/2013	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 2 ended

Active mandates

KOEN HUYGENS

Director

Active

Ended mandates

Koen Huygens

Manager · since 28 avril 2011

Ended

Koen Huygens

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates08/02/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN
PDF
Registered office26/01/2016
MAATSCHAPPELIJKE ZETEL - ADRESSEN ANDERS DAN MAATSCHAPPELIJKE ZETEL
PDF
Other13/05/2011
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202571,4 k €↑
2024
Annual accounts 2024-4,7 k €↓
2023
Annual accounts 202311,4 k €↓
2023
Name changeHEMALEX.BIO.
2022
Annual accounts 2022110,8 k €↓
2021
Annual accounts 2021132,2 k €↑
2019
Annual accounts 201967,7 k €↑
2018
Annual accounts 201860,8 k €↓
2017
Annual accounts 2017105,6 k €↑
2016
Annual accounts 201696,1 k €↑
2015
Annual accounts 20155,9 k €↓
2014
Annual accounts 201410,4 k €↓
2013
Annual accounts 201372 k €↓
2012
Annual accounts 2012121,5 k €
2012
Name changeKOEN HUYGENS
28/04/2011
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

hemalex.bio

Overview

What does hemalex.bio do?

Trend over 13 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline